Telmisartan More Than an Antihypertensive – MM1502
Telmisartan, a well established angiotensin type 1 receptor antagonist,
is indicated for the reduction of cardiovascular morbidity in patients with manifest atherothrombotic cardiovascular disease (CVD) or type 2 diabetes mellitus with documented target organ damage, as well as for the treatment of hypertension.
Modern Medicine – February 2015
